The Lentiviral Vector Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Lentiviral Vector Market?
The market size of the lentiviral vector expanded swiftly in the past few years. The market is expected to increase from $14.37 billion in 2024 to $16.62 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 15.7%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Lentiviral Vector Industry?
The lentiviral vector market is projected to reach $29.41 billion in 2029 with a compound annual growth rate (CAGR) of 15.3%.
Download Your Free Sample of the 2025 Lentiviral Vector Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Lentiviral Vector Market?
The key drivers in the lentiviral vector market are:
• Growth in personalized medicine
• Innovations in gene editing
• Demand for rare disease therapy
• Adoption and improvement of lentiviral vectors
Global Market Segmentation: Identifying Major Lentiviral Vector Industry Segments
The lentiviral vector market covered in this report is segmented –
1) By Product Type: Kits, Reagents And Consumables
2) By Indication: Cancer, Genetic Disorder, Infectious Disease, Veterinary Disease, Other Indications
3) By End User: Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization (CRO), Academic And Research Institutes
Pre-order the 2025 Lentiviral Vector Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Lentiviral Vector Market?
The key trends in the lentiviral vector market are:
• Research and development expansion is a key trend shaping the future of the lentiviral vector market.
• The integration of lentiviral vectors in CAR-T cell therapies is a significant emerging trend.
• The development of next-generation lentiviral vectors is influencing the future growth of the market.
• The use of lentiviral vectors in vaccine development, and the advancement in production technologies are pivotal trends in the industry.
Who Are the Top Competitors & Leading Players in the Lentiviral Vector Market?
Major companies in the lentiviral vector market are:
• Pfizer Inc.
• AbbVie Inc.
• Bayer AG
• Sanofi SA
• Bristol Myers Squibb Company
• Thermo Fisher Scientific Inc.
• AstraZeneca plc
• Novartis AG
• GlaxoSmithKline plc (GSK)
• Eli Lilly and Company
• Agilent Technologies Inc.
• Amgen Inc.
• Merck KGaA
• Lonza Group Ag
• Cytiva
• Charles River Laboratories
• Bio-Rad Laboratories Inc.
• Promega Corporation
• Takara Bio Inc.
• Sino Biological Inc.
• OriGene Technologies Inc.
• Applied Biological Materials Inc.
• Oxford Biomedica
• Sirion-Biotech GmbH
• Yposkesi
Regional Dominance: Which Area Leads the Global Lentiviral Vector Market?
North America was the largest region in the lentiviral vector market in 2024
